Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

Jamie Baumgartner, Jonathan Grinstein, and John Wilkerson go behind the headlines to discuss the implications of personalized gene-editing therapies, more HHS policy and funding updates, and the ...

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how technological advances will impact the ...

The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations ...

As therapeutic modalities evolve, so do the challenges and methodologies associated with maintaining and verifying cleanroom ...

At the 2025 edition of the International Society of Pharmaceutical Engineering (ISPE) Europe Annual Conference, held in ...